adjuvant egfr inhibition in patients with nsclc
Published 10 years ago • 155 plays • Length 8:44Download video MP4
Download video MP3
Similar videos
-
3:41
egfr inhibitors as adjuvant therapy in nsclc
-
2:41
egfr tkis in the adjuvant setting in nsclc
-
10:45
debate: adjuvant egfr-directed therapy for patients with early stage nsclc? - no
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
4:38
egfr tkis as adjuvant therapy in nsclc
-
14:30
adjuvant therapy for egfr mutant nsclc
-
3:52
is adjuvant chemotherapy in egfr mutated nsclc still required?
-
8:30
third-generation egfr inhibitors in nsclc
-
1:02:05
adjuvant egfr-targeted therapy as a game changer in multimodal nsclc management
-
1:35
dr. herbst on the benefit of adjuvant osimertinib in egfr-mutant nsclc
-
3:40
next-generation egfr inhibitors in patients with non-t790m resistance
-
50:38
adjuvant egfr tki therapy in patients with completely resected non-small-cell lung cancer: curren...
-
1:37
dr. levy on the dfs benefit achieved with adjuvant osimertinib in egfr nsclc
-
6:46
selecting a first-line egfr inhibitor in nsclc
-
7:51
nsclc: egfr inhibition and resistance mechanisms
-
1:23
adjuvant treatment of egfr nsclc: standard of care
-
8:37
debate: adjuvant egfr-directed therapy for patients with early stage nsclc? - yes
-
10:20
role of adjuvant osimertinib in early stage nsclc
-
2:33
adaura: osimertinib adjuvant therapy in egfr mutated nsclc